The combination of trastuzumab and pertuzumab administered at approved doses may delay development of trastuzumab resistance by additively enhancing antibody-dependent cell-mediated cytotoxicity
dc.contributor.author | Tóth, Gábor | |
dc.contributor.author | Szöőr, Árpád | |
dc.contributor.author | Simon, László | |
dc.contributor.author | Yarden, Yosef | |
dc.contributor.author | Szöllősi, János | |
dc.contributor.author | Vereb, György | |
dc.date.accessioned | 2016-09-28T12:53:04Z | |
dc.date.available | 2016-09-28T12:53:04Z | |
dc.date.issued | 2016 | |
dc.date.oa | 2017-02-06 | |
dc.date.pasync | 2018-05-19T00:30:24Z | |
dc.date.updated | 2018-05-19T00:30:24Z | |
dc.identifier.citation | mAbs. - 8 : 7 (2016), p. 1361-1370. -mAbs. - 1942-0862. - 1942-0870 | |
dc.identifier.doi | http://dx.doi.org/10.1080/19420862.2016.1204503 | |
dc.identifier.issn | 1942-0862 | |
dc.identifier.issn | 1942-0870 | |
dc.identifier.opac | http://webpac.lib.unideb.hu:8082/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM065721 | |
dc.identifier.uri | http://hdl.handle.net/2437/230720 | |
dc.identifier.url | http://www.tandfonline.com/doi/full/10.1080/19420862.2016.1204503 | |
dc.language | eng | |
dc.rights.access | open access article | |
dc.rights.owner | Taylor & Francis | |
dc.subject.mab | Orvostudományok | |
dc.subject.mab | Elméleti orvostudományok | |
dc.title | The combination of trastuzumab and pertuzumab administered at approved doses may delay development of trastuzumab resistance by additively enhancing antibody-dependent cell-mediated cytotoxicity | |
dc.type | folyóiratcikk |
Fájlok
Eredeti köteg (ORIGINAL bundle)
1 - 1 (Összesen 1)
Nem elérhető
- Név:
- file_up_The combination of trastuzumab and pertuzumab administered at approved doses may delay development of trastuzumab resistance by additively enhancing.pdf
- Méret:
- 1.58 MB
- Formátum:
- Adobe Portable Document Format
- Leírás:
- kiadói változat